Iron Deposition in the Precuneus is Correlated with Mild Cognitive Impairment in Patients with Cerebral Microbleeds: A Quantitative Susceptibility Mapping Study
Overview
Authors
Affiliations
Purpose: The purpose of this study was to define whether mild cognitive impairment (MCI) is associated with iron deposition in rich-club nodes distant from cerebral microbleeds (CMBs) in patients with cerebral small vessel disease (CSVD).
Methods: A total of 64 participants underwent magnetic resonance imaging (MRI) scanning and were separated into three groups, namely, CMB(+), CMB(-), and healthy controls (HCs). We compared their characteristics and susceptibility values of rich-club nodes [e.g., superior frontal gyrus (SFG), precuneus, superior occipital gyrus (SOG), thalamus, and putamen]. We then divided the CMB(+) and CMB(-) groups into subgroups of patients with or without MCI. Then, we analyzed the relationship between iron deposition and MCI by comparing the susceptibility values of rich-club nodes. We assessed cognitive functions using the Montreal Cognitive Assessment (MoCA) and quantified iron content using quantitative susceptibility mapping (QSM).
Results: In the putamen, the CMB(+) and CMB(-) groups had significantly different susceptibility values. Compared with the HCs, the CMB(+) and CMB(-) groups had significantly different susceptibility values for the SFG and SOG. In addition, we found significant differences in the putamen susceptibility values of the CMB(+)MCI(+) group and the two CMB(-) groups. The CMB(+)MCI(+) and CMB(+)MCI(-) groups had significantly different precuneus susceptibility values. The binary logistic regression analysis revealed that only higher susceptibility values of precuneus were associated with a cognitive decline in patients with CMBs, and it indicated statistical significance.
Conclusion: Iron deposition in the precuneus is an independent risk factor for MCI in patients with CMBs. CMBs might influence iron content in remote rich-club nodes and be relevant to MCI.
Mohammadi S, Ghaderi S, Fatehi F Aging Med (Milton). 2024; 7(5):649-667.
PMID: 39507230 PMC: 11535174. DOI: 10.1002/agm2.12363.
Yadav V, Choudhary N, Gacem A, Verma R, Hasan M, Imam M Redox Rep. 2023; 28(1):2269331.
PMID: 38010378 PMC: 11001282. DOI: 10.1080/13510002.2023.2269331.
Multimodal comparisons of QSM and PET in neurodegeneration and aging.
Cogswell P, Fan A Neuroimage. 2023; 273:120068.
PMID: 37003447 PMC: 10947478. DOI: 10.1016/j.neuroimage.2023.120068.